Insights

ND State Updates - 2015 Jan 05 No.01


On April 13, 2015, Gov. Dalrymple signed House Bill 1072 into law. This law requires that copayments, deductibles and coinsurance amounts for patient-administered cancer treatment medications cannot be higher than the amounts for cancer treatment medications that are injected or administered by a health care professional. Insurers may not increase copayments, deductibles or coinsurance amounts for injected or intravenously administered cancer medications or reclassify those benefits to avoid compliance. This law is effective on Aug. 1, 2015.

HB 1072 »